Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
CA125 is the most widely used tumour marker in ovarian cancer with unsatisfactory sensitivity and specificity especially at early stage. It is quantified by antibody-based immunoassays; however different molecular weight isoforms have been described in the literature which have never been validated...
Main Authors: | Florian Weiland, Katarina Fritz, Peter Hoffmann, Martin K. Oehler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/13/8/9942 |
Similar Items
-
Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
by: Peter Hoffmann, et al.
Published: (2012-08-01) -
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
by: Ji Hui Choi, et al.
Published: (2018-05-01) -
CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01) -
Correlation of Cytohistlogical Expression and Serum Level of Ca125 in Ovarian Neoplasm
by: Chhanda Das, et al.
Published: (2014-03-01) -
CA125 and Ovarian Cancer: A Comprehensive Review
by: Parsa Charkhchi, et al.
Published: (2020-12-01)